Nano Therapy  Market Research Report - Forecast Till 2027

Nano Therapy Market Research Report: By Technology (Nanomaterial And Biological Device, Nano Electronic Biosensor, Molecular Nanotechnology, Implantable Cardioverter-Defibrillators), By Application (Cardiovascular Disease, Cancer Therapy, Diabetes Treatment, Rheumatoid Arthritis), By End User (Hospitals, Clinics And Research Institutions) - Forecast Till 2027

ID: MRFR/LS/0419-HCR | October 2022 | Region: Global | 100 Pages         

Nano therapy Market Speak to Analyst Request a Free Sample

Nano therapy Market Scenario


Nanotechnology has the potential to improve the drug solubility, stability, half-lives, and efficiency of the treatment. Nano therapy is a modern technique for treatment of various diseases and performed with the help of submicron sized molecular devices or nanoparticles. Nanotechnology offers the possibility to enhance drug dissolvability and strength, drag out medication half-lives in plasma, minimize off target impacts, and gather drugs at an objective site. This technology is characterized as submicron estimated atomic gadgets or nanoparticles prevalently running from 5 to 500 nm in one dimension. Generous past exploration exertion has brought about techniques to fuse helpful operators into biocompatible Nano devices including polymer nanoparticles, liposomes, micelle frameworks, inorganic nanoparticles, nanotubes, and dendrites.

The market for Nano-therapy is blooming, as of now, around 250 Nano-medical products are being tested or used for humans. Nano therapy is majorly used in the treatment of diseases such as cancer, diabetes, cardiovascular disease and others. The major driving factors for the growth of the market are increasing the prevalence of cancer and other metabolic diseases. A recent study conducted by the Journal of Diabetes and Metabolic diseases has suggested the prevalence of MS ranged from 35.8 to 45.3 % in India and 30.5 to 31.5 % in China. Moreover, continuous development in technology, increasing demand for the better treatment, government support for research and development, and increasing healthcare expenditure of the people have fueled the growth of Nano therapy market. However, lack of regulatory standards in the examination of Nano therapy and higher cost of the treatment are the major factors that may restrict the growth of the market.

The global nano therapy market is expected to grow at a CAGR of 8.2% during the forecast period 2017-2023.

Key Players for Global Nano Therapy Market


Some of the major players for the nano therapy market are Smith and Nephew (UK), Selecta Biosciences, Inc. (US), Sirnaomics, Inc. (US), Tarveda Therapeutics (US), DIM (US), Cristal Therapeutics (the Netherland), CytImmune Science, Inc. (US), Luna (US), NanoBio Corporation (US), NanoBioMagnetics.n.nu (US), Nanobiotix (France), Nanoprobes, Inc. (US), Parvus Therapeutics (US), Nanospectra Biosciences, Inc (US), Nanosphere Inc. (US), NanoMedia Solutions Inc. (Japan).


Segmentation


The global Nano therapy market is segmented on the basis of technologies, applications and end users. On the basis of technology, the market is further segmented into nanomaterial and biological devices, Nano electronic biosensors, molecular nanotechnology, implantable cardioverter-defibrillators, and other. On the basis of applications, the market is segmented into cardiovascular disease, cancer therapy, diabetes treatment, rheumatoid arthritis, and others. On the basis of end users, the nano therapy market is further divided into hospitals, clinics and research institutions.


 Regional Analysis


America dominates the global Nano therapy market owing to large diabetic population. According to National Diabetes Statistics Report, 2017, around 30.3 million people of all ages that is nearly 9.4% of the U.S. population had diabetes in 2015. Moreover, the accessibility of technology, increasing healthcare expenditure, and increasing government support for the research and development are some more factors supporting the growth in this region. Europe is the second largest nanotherapy markets, which is majorly driven by awareness and advancement in the nanotechnology sector. Asia Pacific is the fastest growing market owing to increasing demand for the better treatment options, and rising initiatives to include IT healthcare sector. Whereas, due to less development in technology, and low infrastructure level the market for Middle East & Africa will have limited growth in the nanotherapy market.


 Figure 1- Global Nano Therapy Market, by application Nano therapy Market


Source- U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute,  National Center for Biotechnology Information, U.S. National Library of Medicine Annual reports, press release, white paper, company presentation


 Intended Audience



  • Nano Medical Devices Manufacturer and Supplier

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research And Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes And Universities



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

nano therapy market is projected to grow at an 8.2% CAGR between 2017-2023.

The Americas is projected to lead the nano therapy market.

Nano therapy finds extensive applications in rheumatoid arthritis, diabetes treatment, cancer therapy, cardiovascular disease, among others.

Increasing healthcare expenditure and rising prevalence of cancer are the key factors boosting the nano therapy market growth.

High treatment cost and lack of regulatory standards may restrict the nano therapy market growth.